𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Editorial Comment on: Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study

✍ Scribed by Oudard Stéphane

Book ID
113610574
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
148 KB
Volume
54
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 study of carboplatin plus doce
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi